Kindred Biosciences Inc. (KIN)
NASDAQ: KIN
· Real-Time Price · USD
9.25
0.01 (0.11%)
At close: Apr 24, 2025, 3:47 PM
Kindred Biosciences Revenue
Kindred Biosciences reported an annual revenue of $42.16M, reflecting a 890.7% growth. For the quarter ending June 30, 2021, Kindred Biosciences generated $3.54M in revenue.
Revenue (ttm)
42.16M
Revenue Growth
890.7%
Price / Sales Ratio
4.02
Revenue / Employee
669.27K
Employees
63
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 42.16M | +890.70% |
| Dec 31, 2019 | 4.26M | +116.48% |
| Dec 31, 2018 | 1.97M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |